This report examines the effect of recombinant murine (rm)IL-10 on antigen-induced cellular recruitment into the airways of sensitized Balb/c mice. The intranasal instillation of 10 pug ovalbumin induced an early (6-24 h) increase in the number of neutrophils, and a late rise (24-96 h) in that of eosinophils in the bronchoalveolar lavage (BAL) fluid and bronchial tissue. A single intranasal instillation of 0.01-0
Introduction
Airway infiltration by inflammatory cells, particularly of eosinophils, is one of the characteristic features of asthma (1) . Several mechanisms responsible for the attraction and localization of inflammatory cells at site of allergic reactions have been proposed. Among them, attention is presently focused on the hy-pothesized switching of CD4 + T lymphocytes for the preferential production of Th2-derived cytokines (2) (3) (4) . These cytokines include IL-S, which promotes the growth, differentiation, survival, and activation of eosinophils (5) (6) (7) and 11L-4, which induces IgE production by B cells (8) . In murine models of allergic inflammation, infiltration of the airways by eosinophils is regulated by IL-S and IL-4, since sensitized mice treated with anti-IL-S (9) or anti-IL-4 (10) antibodies display reduced eosinophils in their bronchoalveolar lavage (BAL)' fluid and bronchial tissue after antigen challenge.
IL-10 was initially characterized as a product of CD4+ T lymphocytes of the Th2 subtype ( 11 ) and shown to inhibit IFN-'y production by Thl clones (12) . Several properties of IL-10 on various cell types have been described since then, including growth stimulation of thymocytes, mast cells, and B cells, and inhibition of cytokine production by activated monocytes, macrophages (reviewed in reference 13) and, more recently, by neutrophils (14, 15) and eosinophils (16) . Only a few studies, however, have focused on the in vivo modulatory properties of IL-10 during inflammatory reactions. In particular, Howard et al. (17) and Gerard et al. (18) , recently demonstrated that the administration of IL-10 protects mice from LPS-induced death and the accompanying rise in the levels of circulating TNF-a, suggesting an involvement of IL-10 in inflammatory diseases such as bacterial sepsis. At this time, however, the ability of IL-10 to influence in vivo allergic airway inflammation has not been investigated.
In this report, we show that the intranasal administration of ovalbumin to sensitized Balb/c mice induces an early generation of TNF-a in the BAL fluid, which is followed by airway neutrophilia and eosinophilia. Treatment of the sensitized mice with recombinant murine (rm)IL-10, concurrently administered with ovalbumin, abrogates antigen-induced airway inflammation and TNF-a generation in the BAL fluid, suggesting that IL-10 plays an important role in regulating allergic inflammatory processes in the lung. IgE-like homocytotropic antibodies, as measured by passive cutaneous anaphylaxis ( 19) . Bronchoalveolar cell counts and differentiation. Cellular accumulation into the BAL fluid from sensitized mice was induced by the intranasal instillation of 50 pl of a solution containing 200 jg/mi ovalbumin diluted in sterile saline (10 jg ovalbumin, as final dose administered).
Control animals received the same volume of sterile saline. At various time intervals after challenge, mice were anesthetized by an intraperitoneal injection of 4 mg/kg sodium pentobarbital (Clin-Midy, Montpellier, France) and bronchoalveolar cells were collected in four successive lavages using 1-ml aliquots of sterile saline at room temperature, injected, and recovered through a polyethylene tracheal cannula. Total cells were counted using a Coulter Counter ZM (Coultronics, Margency, France). Differential cell counts were performed after cytocentrifugation (Hettich Universal, Tuttlingen, Germany) and staining with DiffQuik stain (Baxter Dade AG, Duedingen, Switzerland). Results are expressed as the number of each population per milliliter BAL fluid. Aliquots of 0.5 ml of the remaining lavage fluid were centrifuged at 200 g for 15 min, at 40C and the supernatant was collected and stored at -80'C until the determination of TNF-a, as described below.
Histology. After the BAL collection was performed as described above, mice were exsanguinated via the abdominal aorta and the lungs were inflated by injecting into the trachea 1 ml solution of optimum cutter temperature compound (BDH, Poole, United Kingdom) in distilled water (vol/vol). The lobes were dissected and mounted over cork disks, covered by optimum cutter temperature compound and snap frozen in isopentane (Prolabo, Paris, France) cooled by liquid nitrogen. The frozen blocks were kept at -80'C before use. Sections alongside the main intrapulmonary bronchus were cut in a cryostat kept at -210C and collected on glass slides previously coated with y-methacryloxypropyltrimethoxysilane (Sigma Chemical Co., St. Louis, MO), fixed in acetone (Merck) for 10 min, wrapped in a plastic film, and kept at -20'C before use. Cyanide-resistant eosinophil peroxidase (EPO) activity, using potassium cyanide, diaminobenzidine, and hydrogen peroxide (Merck), was used to stain the eosinophils (20) .
Sections were coded and read in a blind fashion. Positive cells were enumerated in the bronchial submucosa by means of a micrometer. The results of each stained slide were expressed as the number of EPOpositive cells per millimeter of basal lamina.
Effect of murine rmIL-10. To determine whether IL-10 regulates antigen-induced cellular infiltration into the airways, sensitized mice In preliminary experiments, the subcutaneous administration of 0. challenged untreated mice, respectively.
In both series of experiments, cell counts in the BAL fluid were evaluated 6 and 24 h after antigen challenge.
TNF-a determination. The levels of TNF-a in the supernatant of BAL fluid from sensitized saline-or ovalbumin-challenged untreated or rmIL-10 (0.1 or 0.5 Mg) -treated mice were determined by a specific double sandwich ELISA. Briefly, ELISA plates (96-well-Immuno Plate MaxiSorp; Nunc, Roskilde, Denmark) were coated with 100 il of a rat anti-mTNF-a mAb (Clinisciences-Endogen, Montrouge, France), at 5 Mg/ml in PBS, pH 7.4, and incubated overnight at room temperature in the dark. The day after, the wells were washed three times with PBS containing 0.1% Tween 20 (PBS-T) and 200 ML of PBS-T containing 0.1% BSA (PBS-T-BSA) were added to each well.
After 1 h at 370C followed by three washes with PBS-T-BSA, 100
Ml of the samples or rmTNF-a standards (kindly provided by Dr. G. R.
Adolf, Boehringer Institut fUr Arzneimmittel-Forschung, Vienna, Austria), at concentrations ranging between 50 and 3,200 pg/ml in PBS-T-BSA were added to each well and incubated at 370C for 1 h. The wells were washed three times with PBS-T and incubated for 1 h at 370C with 100 Ml of a solution of polyclonal rabbit anti-mTNF-a (Clinisciences-Endogen), at 5 Mg/ml in PBS-T-BSA. After the wells were washed three times with PBS-T, 
Results
Kinetics ofantigen-induced cellular infiltration in the BALfluid from sensitized mice. The intranasal instillation of 10 jig ovalbumin to sensitized Balb/c mice, induced a rise in the number of neutrophils in the BAL fluid, which reached a maximum between 6 and 24 h and resolved thereafter (Fig. 1) . Intense eosinophil accumulation was observed at 24 h and progressively increased until 96 h (Fig. 1) . The number of eosinophils returned to background levels 14 d after antigen challenge (data not shown).
No changes in alveolar macrophage counts were observed, atany time point after antigen administration (data not shown).
Nonimmunized mice challenged with ovalbumin show a number of neutrophils in the BAL fluid similar to that found in sensitized saline-challenged animals. No eosinophils were enumerated at 24 h (data not shown).
The times of 6 and 24 h were selected to study the effect Effect of rmIL-10 on antigen-induced cellular infiltration in the BALfluid and bronchial tissuefrom sensitized mice. A single intranasal administration of 0.01, 0.03, or 0.1 1jg rmIL-10 to sensitized mice, instilled concurrently with ovalbumin, inhibited dose-dependently neutrophil and eosinophil infiltration in the BAL fluid observed 6 and 24 h after the challenge, respectively (Fig. 2) . At the highest dose (0.1 psg/mouse), rmEL-10 suppressed allergic neutrophilia and decreased by 75% eosinophilia (P < 0.001).
A kinetics study showed significant protection of both BAL neutrophilia and eosinophilia until 24 h after ovalbumin and rmIL-10 (0.1 jg) administration (Fig. 3) . In particular, neutrophil numbers in ovalbumin-challenged rmIL-10-treated mice were below those found in control saline-stimulated animals ( Fig. 3) . At 96 h, however, only a slight and nonsignificant decrease in the numbers of eosinophils was noted in antigenchallenged rmIL-lO (0.1 Mg) -treated mice, as opposed to controls (Fig. 3) . Antigen challenge also induced a time-dependent rise in the number of eosinophils in the bronchial tissue, mainly at 24 h (Figs. 4 and 5) . Treatment with 0.1 gg rmIL-10, markedly decreased ovalbumin-induced eosinophil infiltration in the bronchial tissue and significant inhibition was observed at 24 h (Figs. 4 and 5) .
The intranasal administration of 0.1 1g rmIL-10, 1 or 3 h after antigen challenge, failed to protect sensitized mice from antigen-induced cellular accumulation in the BAL fluid (Table I).
Effect of anti-IL-10 mAb on antigen-induced cellular infiltration in the BAL fluid from sensitized mice. IL-10-mediated inhibition of allergic airway inflammation was suppressed by the prior (1 h) intravenous administration of 1 mg/mouse of the rat anti-mouse IL-10 mAb, 2A5, but not of its matched isotype, GL1 13 ( Fig. 6 ), indicating that tte effect of rmIL-10 was due exclusively to its biological activity.
In separate experiments, the in vivo neutralization of IL-10 led to a significant (P < 0.05, n = 4-6) increase in the number of neutrophils and eosinophils in the BAL fluid 6 and 24 h after the challenge, respectively, (data not shown). This effect was not an artifact, since the intravenous injection of 1 mg GL1 13 or 2A5 to sensitized unchallenged mice did not modify the number of the different cell types in BAL fluid (data not shown).
Effect of rmIL-10 on antigen-induced TNF-a generation in the BALfluidfrom sensitized mice. Antigen challenge by sensitized mice was also followed by a time-dependent generation of TNF-a in the BAL fluid, which peaked at 1 h and returned (Fig. 7) . BAL fluids collected 1, 3, or 24 h after the simultaneous administration of ovalbumin and rmIL-10 indicated a substantial reduction in the levels of TNFa (Fig. 7) . Total inhibition at 1 h was achieved with 0.5 tig rmIL-10, since 241.0±46.2 and 69.0±4.8 pg/ml TNF-a were measured in the BAL fluid of antigen-challenged untreated or rmIL-10-treated mice, respectively, (P < 0.001, n = 5-9). Effect of anti-TNF-a antiserum on antigen-induced cellular infiltration in the BALfluidfrom sensitized mice. The intranasal instillation of 50 ILI of a specific anti-TNF-a antiserum, concomitantly with ovalbumin, led to a significant reduction in both BAL neutrophils and eosinophils at 6 and 24 h, respectively. Under the same conditions, control serum was ineffective (Table II) .
Discussion
In the present study we show that IL-10, a Th2-derived cytokine ( 11), down-regulates antigen-induced airway inflammation in sensitized mice, since its local administration prevents neutrophil and eosinophil accumulation in the BAL fluid observed 6 and 24 h after the challenge, respectively. This effect is attributable to the biological activity of the cytokine, since inhibition by IL-10 of antigen-induced airway inflammation is suppressed when the sensitized mice are treated with a specific anti-IL-10 mAb. It is noteworthy that in vivo neutralization of IL-10 further enhances the ovalbumin-induced cellular recruitment in the BAL fluid, suggesting that endogenously released IL-10 may be involved in the regulation of leukocyte homing to the airways. Systemic generation of IL-10 after intraperitoneal injection of anti-CD3 mAb or LPS to Balb/c mice has been reported by Durez et al. (22) . Since both stimuli were effective in eliciting IL-10 release, it was suggested that IL-10 production can be t achieved by stimulating different cell types. Thus, CD4 + T cells are the major source of this cytokine upon CD3 stimulation (23) , whereas macrophages and B cells are likely to be involved I in LPS-induced IL-10 release (13). These observations raise the question of the sources of IL-10 in ovalbumin-challenged mouse lung. Indeed, besides CD4 + T lymphocytes, which are present in increased numbers in the bronchial tissue of sensitized mice 24 h after antigen challenge (reference 9 and our unpublished results), alveolar macrophages may also respond to antigen stimulation with IL-10 generation. Accordingly, Hamid et al. (24) described recently increased mRNA for IL-10 in BAL cells from asthmatics. In situ hybridization coupled with immunohistochemistry, revealed that IL-10 secreting cells were mostly T lymphocytes and macrophages (24) . Contrary to the inhibition of allergic airway inflammation observed when rmIL-1O was given by intranasal route, its subcutaneous injection did not modify antigen-induced cellular accumulation in the BAL fluid (data not shown). These results suggest that the target(s) for IL-10 are located in the airways and that the amounts of rmIL-10 reaching the bronchial compartment after its systemic administration are probably not sufficient to display an effect. Among the various bronchopulmonary targets for IL-10, the macrophage is a widely described cell type sensitive to this cytokine (13) . Indeed, incubation of human or murine macrophages in the presence of IL-10 results in a marked down-regulation of their reactivity, particularly in terms of cytokine production and mediator release (25) (26) (27) . On the other hand, IL-lO was first identified as a cytokine acting on ThI clones and capable of inhibiting their 1FN-y production (11, 12) . However, protection by IL-1O of antigen-induced airway inflammation presently described seems unrelated to a blockade of IFN-y generation from lung T cells. Indeed, systemic (28) or bronchopulmonary (29) administration of IFNy to mice sensitized and challenged under conditions similar to those used in this study, prevents allergic eosinophil infiltration into the tracheal tissue. This effect is compatible with the inhibition by IFN-y of Th2 clone proliferation (30) , and subsequent production of cytokines, such as IL-5, which is selectively involved in eosinophil mobilization (5) (6) (7) . The data presented herein show that rmIL-10 is equally effective in preventing both neutrophil and eosinophil infiltration into the airways of antigen-challenged mice. This suggests that IL-10 may regulate the expression and/or the release of factors involved in the migration of these two cell types to the lung. Interestingly enough, when administered 1 h after the challenge, rmIL-10 failed to protect sensitized mice from antigen-induced cellular accumulation in the BAL fluid. This observation led us to hypothesize that IL-10 may modulate the local release of preformed and thus rapidly released cytokines, which are potentially involved in allergic leukocyte recruitment.
Several lines of evidence designate TNF-a as a cytokine generated by numerous cell types during inflammatory reactions and shock states (reviewed in reference 31). The participation of TNF-a in allergic reactions is linked to different observations, including its release by mast cells, basophils, and alveolar macrophages upon IgE-dependent mechanisms (32) (33) (34) (35) . High levels of TNF-a have been shown in monocytes and epithelial cells from asthmatics (36) and BAL fluid from antigen-challenged guinea pigs (37) . Finally, treatment of sensitized guinea pigs with an IL-l receptor antagonist prevents antigen-induced eosinophil accumulation and TNF-a generation in the BAL fluid (37) , indicating that TNF-a may modulate allergic airway inflammation. We thus investigated whether antigen challenge induced the release of this cytokine in the BAL fluid of sensitized mice and verified the potential modulatory activity of IL-10 in this process. The intranasal administration of ovalbumin was followed by a marked rise in the levels of TNF-a in the BAL fluid, which reached a peak at 1 h to resolve between 3 and 6 h after the challenge. rmIL-I0 dose-dependently inhibited this release, a result extending previous observations showing reduction by IL-10 of LPS-induced in vivo TNF-a generation (16, 17) . Thus, the observation that TNF-a released upon antigenic stimulation is also susceptible of inhibition by IL- IL-10 to modify antigen-induced cellular infiltration when administered 1 h after the challenge, i.e., the time of the peak release of TNF-a in the BAL fluid, support the hypothesis that blockade of local TNF-a generation and inhibition of leukocyte recruitment are related phenomena. In confirmation, we demonstrate that the local administration of an antiserum to TNF-a markedly reduced antigen-induced neutrophil and eosinophil accumulation in the BAL fluid. These results extend those from previous studies showing the participation of TNF-a in leukocyte infiltration associated with IgE-dependent cutaneous inflammation in sensitized mice (38) .
As whole rat lung tissue passively sensitized with monoclonal IgE antibody was shown to produce TNF-a after antigen stimulation (39) , the presence of bronchopulmonary source(s) for this cytokine, particularly macrophages and mast cells, has been suggested. Indeed, macrophages, which are directly involved in allergic responses through the presence of FcERII receptors at their surface (40) , produce and express TNF-a upon IgE-dependent stimulation (35) . Similarly, IgE-mediated activation of mast cells triggers the release of TNF-a, which, in this cell type, is stored in the cytoplasmic granules (41 ) and rapidly secreted upon stimulation. However, while macrophage deactivation by IL-10 is well documented (13, (25) (26) (27) , modulation by IL-10 of IgE-dependent responses on mast cells, including TNF-a generation, has not been described yet.
Once released in the airways, TNF-a may display a broad spectrum of biological activities, including activation and chemotaxis of eosinophils (42, 43) and neutrophils (44, 45) . Interestingly enough, TNF-a directly stimulates the expression of adhesion molecules on cultured endothelial cells (46, 47) , and, in vivo, in the baboon's skin (48) . These molecules, which include intercellular adhesion molecule-I (ICAM-I) and vascular cell adhesion molecule-i (VCAM-1), are responsible for the adhesion of leukocytes to the endothelium. This is followed by their transendothelial migration and subsequent infiltration into the inflamed tissues. Accordingly, treatment of sensitized Balb/c mice with anti-ICAM-l or anti-VCAM-1 mAbs, suppressed antigen-induced cellular recruitment into the tracheal tissue (49) . Whether adhesion molecule expression in the allergic lung is also directly or indirectly regulated by IL-10 is an area for a further investigation.
In conclusion, our findings demonstrate that, when compared to other Th2-derived cytokines, such as IL-4 and IL-5, IL-10 is unique in down-regulating antigen-induced airway inflammation in the mouse. This evidence suggests that IL-10 production during allergic responses, may represent an important regulatory mechanism in the control of tissue inflammation in which leukocyte infiltration is a prominent feature. Consequently, therapeutic agents aimed to positively regulate IL-1O generation and/or its receptor interaction may have a promising future as inhibitors of allergic bronchopulmonary inflammation.
